The nice people at the transfusion Evidence Alert sent their update today. It was heavily biased toward COVID-19 (i.e. didn’t mention anything else) but then this is the world we live in these days.
TOP ARTICLES
International Survey of Trials of Convalescent Plasma to Treat COVID-19 Infection
Murphy, M. F. Estcourt L. Grant-Casey J. Dzik S. (2020). Transfusion Medicine Reviews
Full text
Venous thromboembolism in COVID-19: systematic review of reported risks and current guidelines
Fontana, P., Casini, A., Robert-Ebadi, H., Glauser, F., Righini, M. and Blondon, M. (2020).
Swiss Med Wkly
Characteristics and serological patterns of COVID-19 convalescent plasma donors: optimal donors and timing of donation
Li, L., Tong, X., Chen, H., He, R., Lv, Q., Yang, R., Zhao, L., Wang,
J., Xu, H., Liu, C., Chen, G., Chen, S., Li, C., Qiao, J., Yang, J., Wu,
Y. and Liu, Z. (2020).
Transfusion
Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review
Piechotta, V., Chai, K. L., Valk, S. J., Doree, C., Monsef, I., Wood, E.
M., Lamikanra, A., Kimber, C., McQuilten, Z., So-Osman, C., Estcourt,
L. J. and Skoetz, N. (2020).
Cochrane Database Syst Rev
HIGHLIGHTED ARTICLE Effects of the COVID-19 pandemic on supply and use of blood for transfusion |
|
|
No comments:
Post a Comment